Kinetics of Intrahepatic Covalently Closed Circular DNA and Serum Hepatitis B Surface Antigen During Antiviral Therapy for Chronic Hepatitis B: Lessons From Experimental and Clinical Studies

被引:30
作者
Zoulim, Fabien [1 ]
Testoni, Barbara
Lebosse, Fanny
机构
[1] INSERM, U1052, F-69008 Lyon, France
关键词
VIRUS INFECTION; HEPATOCELLULAR-CARCINOMA; CCCDNA; HBSAG; ADEFOVIR; PERSISTENCE; MANAGEMENT; CLEARANCE; DECLINE; RISK;
D O I
10.1016/j.cgh.2013.04.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1011 / 1013
页数:3
相关论文
共 24 条
[1]   IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome [J].
Belloni, Laura ;
Allweiss, Lena ;
Guerrieri, Francesca ;
Pediconi, Natalia ;
Volz, Tassilo ;
Pollicino, Teresa ;
Petersen, Joerg ;
Raimondo, Giovanni ;
Dandri, Maura ;
Levrero, Massimo .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (02) :529-537
[2]   Clearance of Serum HBsAg and Anti-HBs Seroconversion Following Antiviral Therapy for Chronic Hepatitis B [J].
Borgniet, Olivier ;
Parvaz, Parviz ;
Bouix, Cecile ;
Chevallier, Philippe ;
Trepo, Christian ;
Andre, Patrice ;
Zoulim, Fabien .
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (08) :1336-1342
[3]   Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B [J].
Chang, Ting-Tsung ;
Liaw, Yun-Fan ;
Wu, Shun-Sheng ;
Schiff, Eugene ;
Han, Kwang-Hyub ;
Lai, Ching-Lung ;
Safadi, Rifaat ;
Lee, Samuel S. ;
Halota, Waldemar ;
Goodman, Zachary ;
Chi, Yun-Chan ;
Zhang, Hui ;
Hindes, Robert ;
Iloeje, Uchenna ;
Beebe, Suzanne ;
Kreter, Bruce .
HEPATOLOGY, 2010, 52 (03) :886-893
[4]   Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely [J].
Chevaliez, Stephane ;
Hezode, Christophe ;
Bahrami, Stephane ;
Grare, Marion ;
Pawlotsky, Jean-Michel .
JOURNAL OF HEPATOLOGY, 2013, 58 (04) :676-683
[5]   Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro [J].
Delmas, J ;
Schorr, O ;
Jamard, C ;
Gibbs, C ;
Trépo, C ;
Hantz, O ;
Zoulim, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :425-433
[6]   Selection of chronic hepatitis B therapy with high barrier to resistance [J].
Gish, Robert ;
Jia, Ji-Dong ;
Locarnini, Stephen ;
Zoulim, Fabien .
LANCET INFECTIOUS DISEASES, 2012, 12 (04) :341-353
[7]   Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? [J].
Janssen, Harry L. A. ;
Sonneveld, Milan J. ;
Brunetto, Maurizia R. .
GUT, 2012, 61 (05) :641-645
[8]  
Lacombe K, 2013, HEPATOLOGY
[9]   Characterization of the antiviral effect of 2′,3′-dideoxy-2′, 3′-didehydro-β-L-5-fluorocytidine in the duck hepatitis B virus infection model [J].
Le Guerhier, F ;
Pichoud, C ;
Guerret, S ;
Chevallier, M ;
Jamard, C ;
Hantz, O ;
Li, XY ;
Chen, SH ;
King, I ;
Trépo, C ;
Cheng, YC ;
Zoulim, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :111-122
[10]   Antiviral activity of β-L-2′,3′-dideoxy-2′,3′-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus [J].
Le Guerhier, F ;
Pichoud, C ;
Jamard, C ;
Guerret, S ;
Chevallier, M ;
Peyrol, S ;
Hantz, O ;
King, I ;
Trépo, C ;
Cheng, YC ;
Zoulim, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1065-1077